This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Xeljanz® (tofacitinib), Enbrel®(etanercept) and Inflectra® (infliximab) and ▼Ruxience (rituximab) Great Britain (GB) and Northern Ireland (NI) and Maxtrex (methotrexate) United Kingdom (UK)

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Xeljanz (tofacitinib) 5mg film-coated tablets - PI for GB
  • Xeljanz (tofacitinib) 10mg film-coated tablets - PI for GB
  • Xeljanz (tofacitinib) 11mg prolonged release tablets - PI for GB 
  • Xeljanz (tofacitinib) 1mg/ml Oral Solution - PI for GB

Northern Ireland

  • Xeljanz (tofacitinib) 5mg and 10mg film-coated tablets - PI for NI
  • Xeljanz (tofacitinib) 11mg prolonged release tablets - PI for NI
  • Xeljanz (tofacitinib) 1mg/ml Oral Solution - PI for NI

Great Britain

  • Enbrel (etanercept) 10mg powder and solvent for solution for injection for paediatric use - PI for GB
  • Enbrel (etanercept) 25mg solution for injection in pre-filled pen - PI for GB
  • Enbrel (etanercept) 25mg solution for injection in pre-filled syringe - PI for GB
  • Enbrel (etanercept) 50mg solution for injection in pre-filled syringe - PI for GB
  • Enbrel (etanercept) 50mg solution for injection in pre-filled pen - PI for GB
  • Enbrel (etanercept) 25mg powder and solvent for solution for injection - PI for GB

Northern Ireland

  • Enbrel (etanercept) 25mg and 50mg solution for injection in pre-filled pen - PI for NI
  • Enbrel (etanercept) 25mg and 50mg solution for injection in pre-filled syringe - PI for NI
  • Enbrel (etanercept) 25mg powder and solvent for solution for injection - PI for NI

Great Britain

  • Ruxience (rituximab) 100mg concentrate for solution for infusion - PI for GB
  • Ruxience (rituximab) 500mg concentrate for solution for infusion - PI for GB

Northern Ireland

  • Ruxience (rituximab) 100mg and 500mg concentrate for solution for infusion - PI for NI

Great Britain

  • Inflectra (infliximab) 100mg powder for concentrate for solution for infusion - PI for GB

Northern Ireland

  • Inflectra (infliximab) 100mg powder for concentrate for solution for infusion - PI for NI

United Kingdom

  • Maxtrex (methotrexate) 2.5mg tablets – PI for UK

Xeljanz (tofacitinib) 5mg film-coated tablets - PI for GB

Xeljanz (tofacitinib) 10mg film-coated tablets - PI for GB

Xeljanz (tofacitinib) 11mg prolonged release tablets - PI for GB

Xeljanz (tofacitinib) 1mg/ml Oral Solution - PI for GB

Xeljanz (tofacitinib) 5mg and 10mg film-coated tablets - PI for NI

Xeljanz (tofacitinib) 11mg prolonged release tablets - PI for NI

Xeljanz (tofacitinib) 1mg/ml Oral Solution - PI for NI

Enbrel (etanercept) 10mg powder and solvent for solution for injection for paediatric use - PI for GB

Enbrel (etanercept) 25mg solution for injection in pre-filled pen - PI for GB

Enbrel (etanercept) 25mg solution for injection in pre-filled syringe - PI for GB

Enbrel (etanercept) 50mg solution for injection in pre-filled syringe - PI for GB

Enbrel (etanercept) 50mg solution for injection in pre-filled pen - PI for GB

Enbrel (etanercept) 25mg powder and solvent for solution for injection - PI for GB

Enbrel (etanercept) 25mg and 50mg solution for injection in pre-filled pen - PI for NI

Enbrel (etanercept) 25mg and 50mg solution for injection in pre-filled syringe - PI for NI

Enbrel (etanercept) 25mg powder and solvent for solution for injection - PI for NI

Inflectra (infliximab) 100mg powder for concentrate for solution for infusion - PI for GB

Inflectra (infliximab) 100mg powder for concentrate for solution for infusion - PI for NI

Ruxience (rituximab) 100mg concentrate for solution for infusion - PI for GB

Ruxience (rituximab) 500mg concentrate for solution for infusion - PI for GB

Ruxience (rituximab) 100mg and 500mg concentrate for solution for infusion - PI for NI

Maxtrex (methotrexate) 2.5mg tablets – PI for UK

PP-ENB-GBR-1183 February 2024